2009 - NANETS https://nanets.net/abstracts-archive/2009?format=html Thu, 15 Feb 2018 10:07:18 -0500 en-GB hourly 1 C35 – Daily Oral Everolimus Activity in Patients with Metastatic Pancreatic Neuroendocrine Tumors after Failure of Cytotoxic Chemotherapy: A Phase II Trial https://nanets.net/abstracts-archive/2009/49-daily-oral-everolimus-activity-in-patients-with-metastatic-pancreatic-neuroendocrine-tumors-after-failure-of-cytotoxic-chemotherapy-a-phase-ii-trial?format=html C35 – Daily Oral Everolimus Activity in Patients with Metastatic Pancreatic Neuroendocrine Tumors after Failure of Cytotoxic Chemotherapy: A Phase II Trial James C. Yao, Catherine Lombard-Bohas, Eric Baudin, Larry K. Kvols, Philippe Rougier, Philippe Ruszniewski, Sakina Hoosen, Jessica St. Peter, Tomas Haas, David Lebwohl, Eric Van Cutsem, Matthew Kulke, Timothy J. Hobday, Thomas M. O'Dorisio, Manisha H. Shah, Guillaume Cadiot, Gabriele Luppi, James A. Posey, Bertram Wiedenmann for the RADIANT- Study Group

]]> https://nanets.net/abstracts-archive/2009/49-daily-oral-everolimus-activity-in-patients-with-metastatic-pancreatic-neuroendocrine-tumors-after-failure-of-cytotoxic-chemotherapy-a-phase-ii-trial?format=html James C. Yao, Catherine Lombard-Bohas, Eric Baudin, Larry K. Kvols, Philippe Rougier, Philippe Ruszniewski, Sakina Hoosen, Jessica St. Peter, Tomas Haas, David Lebwohl, Eric Van Cutsem, Matthew Kulke, Timothy J. Hobday, Thomas M. O'Dorisio, Manisha H. Shah, Guillaume Cadiot, Gabriele Luppi, James A. Posey, Bertram Wiedenmann for the RADIANT- Study Group

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:18 -0500 C33 – Lymphatic Mapping Helps Define Resection Margins for Midgut Carcinoids https://nanets.net/abstracts-archive/2009/47-lymphatic-mapping-helps-define-resection-margins-for-midgut-carcinoids?format=html C33 – Lymphatic Mapping Helps Define Resection Margins for Midgut Carcinoids Wang, Yi-Zarn DDS, MD, Joseph, Saju MD, Lindholm, Erika BSE, Lyons, John MD, Boudreaux, J. Philip MD, Woltering, Eugene A. MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2009/47-lymphatic-mapping-helps-define-resection-margins-for-midgut-carcinoids?format=html Wang, Yi-Zarn DDS, MD, Joseph, Saju MD, Lindholm, Erika BSE, Lyons, John MD, Boudreaux, J. Philip MD, Woltering, Eugene A. MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:17 -0500 C34 – Pasireotide LAR in Metastatic Carcinoid Tumors: A Randomized Phase I Study https://nanets.net/abstracts-archive/2009/48-pasireotide-lar-in-metastatic-carcinoid-tumors-a-randomized-phase-i-study?format=html C34 – Pasireotide LAR in Metastatic Carcinoid Tumors: A Randomized Phase I Study Edward. M. Wolin, Larry K. Kvols, Shereen Ezzat, Walter I. Kocha, Brigitte Weisshaar, Ke Hu, Pharis Mohideen, Eric Van Cutsem

 Download Poster

]]> https://nanets.net/abstracts-archive/2009/48-pasireotide-lar-in-metastatic-carcinoid-tumors-a-randomized-phase-i-study?format=html Edward. M. Wolin, Larry K. Kvols, Shereen Ezzat, Walter I. Kocha, Brigitte Weisshaar, Ke Hu, Pharis Mohideen, Eric Van Cutsem

 Download Poster

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:17 -0500 C31 – The Utility of F-18 DOPA PET/CT in Identifying Unknown Site of Primary https://nanets.net/abstracts-archive/2009/45-the-utility-of-f-18-dopa-pet-ct-in-identifying-unknown-site-of-primary?format=html C31 – The Utility of F-18 DOPA PET/CT in Identifying Unknown Site of Primary Damita Thomas MD, Yusuf Menda MD, David Bushnell MD, Thomas O’Dorisio MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2009/45-the-utility-of-f-18-dopa-pet-ct-in-identifying-unknown-site-of-primary?format=html Damita Thomas MD, Yusuf Menda MD, David Bushnell MD, Thomas O’Dorisio MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:15 -0500 C32 – Relationship Between Quality Of Life And Health-Related Measures Including https://nanets.net/abstracts-archive/2009/46-relationship-between-quality-of-life-and-health-related-measures-including?format=html C32 – Relationship Between Quality Of Life And Health-Related Measures Including Etta Vinik, Maria Silva, Aaron Vinik

 Download Poster

]]> https://nanets.net/abstracts-archive/2009/46-relationship-between-quality-of-life-and-health-related-measures-including?format=html Etta Vinik, Maria Silva, Aaron Vinik

 Download Poster

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:15 -0500 C30 – Initial Impact of a Systematic Multidisciplinary Approach on the Management of Patients with Gastroenteropancreatic Neuroendocrine Tumor https://nanets.net/abstracts-archive/2009/44-initial-impact-of-a-systematic-multidisciplinary-approach-on-the-management-of-patients-with-gastroenteropancreatic-neuroendocrine-tumor?format=html C30 – Initial Impact of a Systematic Multidisciplinary Approach on the Management of Patients with Gastroenteropancreatic Neuroendocrine Tumor Department of Endocrinology & Diabetes Mellitus, St Vincent’s University Hospital, Dublin, Ireland Department of Pathology & Laboratory Medicine, St Vincent’s University Hospital, Dublin, Ireland Department of Radiology, St Vincent’s University Hospital, Dublin, Ireland Liver Transplant Unit, St Vincent’s University Hospital, Dublin, Ireland Department of Medical Oncology, St Vincent’s University Hospital, Dublin, Ireland Department of Gastroenterology, St James’s Hospital, Dublin, Ireland

 Download Poster

]]> https://nanets.net/abstracts-archive/2009/44-initial-impact-of-a-systematic-multidisciplinary-approach-on-the-management-of-patients-with-gastroenteropancreatic-neuroendocrine-tumor?format=html Department of Endocrinology & Diabetes Mellitus, St Vincent’s University Hospital, Dublin, Ireland Department of Pathology & Laboratory Medicine, St Vincent’s University Hospital, Dublin, Ireland Department of Radiology, St Vincent’s University Hospital, Dublin, Ireland Liver Transplant Unit, St Vincent’s University Hospital, Dublin, Ireland Department of Medical Oncology, St Vincent’s University Hospital, Dublin, Ireland Department of Gastroenterology, St James’s Hospital, Dublin, Ireland

 Download Poster

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:14 -0500 C28 – Phase II Study of Sunitinib Following Hepatic Artery Embolization for Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) https://nanets.net/abstracts-archive/2009/42-phase-ii-study-of-sunitinib-following-hepatic-artery-embolization-for-metastatic-gastroenteropancreatic-neuroendocrine-tumors-gep-nets?format=html C28 – Phase II Study of Sunitinib Following Hepatic Artery Embolization for Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) H. Lee Moffitt Cancer Center, Tampa, FL

]]> https://nanets.net/abstracts-archive/2009/42-phase-ii-study-of-sunitinib-following-hepatic-artery-embolization-for-metastatic-gastroenteropancreatic-neuroendocrine-tumors-gep-nets?format=html H. Lee Moffitt Cancer Center, Tampa, FL

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:13 -0500 C29 – The Antiproliferative Effect of Octreotide in Gastroenteropancreatic (GEP) Neuroendocrine Tumors (NETs) https://nanets.net/abstracts-archive/2009/43-the-antiproliferative-effect-of-octreotide-in-gastroenteropancreatic-gep-neuroendocrine-tumors-nets?format=html C29 – The Antiproliferative Effect of Octreotide in Gastroenteropancreatic (GEP) Neuroendocrine Tumors (NETs) Jonathan Strosberg MD and Larry Kvols MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2009/43-the-antiproliferative-effect-of-octreotide-in-gastroenteropancreatic-gep-neuroendocrine-tumors-nets?format=html Jonathan Strosberg MD and Larry Kvols MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:13 -0500 C27 – First-Line Treatment of Metastatic Pancreatic Endocrine Carcinomas with Capecitabine and Temozolomide https://nanets.net/abstracts-archive/2009/41-first-line-treatment-of-metastatic-pancreatic-endocrine-carcinomas-with-capecitabine-and-temozolomide?format=html C27 – First-Line Treatment of Metastatic Pancreatic Endocrine Carcinomas with Capecitabine and Temozolomide Jonathan Strosberg MD, Junsung Choi MD, Aejaz Nasir MD, Larry Kvols MD

]]> https://nanets.net/abstracts-archive/2009/41-first-line-treatment-of-metastatic-pancreatic-endocrine-carcinomas-with-capecitabine-and-temozolomide?format=html Jonathan Strosberg MD, Junsung Choi MD, Aejaz Nasir MD, Larry Kvols MD

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:12 -0500 C26 – Initial Evaluation of Patients with NETS: A Prospective Evaluation of the Influence of Intensive Pre-Visit Counseling https://nanets.net/abstracts-archive/2009/40-initial-evaluation-of-patients-with-nets-a-prospective-evaluation-of-the-influence-of-intensive-pre-visit-counseling?format=html C26 – Initial Evaluation of Patients with NETS: A Prospective Evaluation of the Influence of Intensive Pre-Visit Counseling Pamela Ryan BSN RN, Jarret Brashear BS, Yi-Zarn Wang MD, Lowell B. Anthony MD, J. Philip Boudreaux MD, Saju Joseph MD, Richard Campeau MD and Eugene A. Woltering MD

]]> https://nanets.net/abstracts-archive/2009/40-initial-evaluation-of-patients-with-nets-a-prospective-evaluation-of-the-influence-of-intensive-pre-visit-counseling?format=html Pamela Ryan BSN RN, Jarret Brashear BS, Yi-Zarn Wang MD, Lowell B. Anthony MD, J. Philip Boudreaux MD, Saju Joseph MD, Richard Campeau MD and Eugene A. Woltering MD

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:11 -0500 C24 – Sunitinib versus Placebo for the Treatment of Progressive, Well-Differentiated Pancreatic Islet Cell Tumors: A Phase III, Randomized, Double-Blind Trial https://nanets.net/abstracts-archive/2009/38-sunitinib-versus-placebo-for-the-treatment-of-progressive-well-differentiated-pancreatic-islet-cell-tumors-a-phase-iii-randomized-double-blind-trial?format=html C24 – Sunitinib versus Placebo for the Treatment of Progressive, Well-Differentiated Pancreatic Islet Cell Tumors: A Phase III, Randomized, Double-Blind Trial Eric Raymond, Jean-Luc Raoul, Patricia Niccoli, Yung-Jue Bang, Ivan Borbath, Catherine Lombard-Bohas, Peter Metrakos, Dongrui-Ray Lu, Carolyn Blanckmeister, Aaron Vinik

]]> https://nanets.net/abstracts-archive/2009/38-sunitinib-versus-placebo-for-the-treatment-of-progressive-well-differentiated-pancreatic-islet-cell-tumors-a-phase-iii-randomized-double-blind-trial?format=html Eric Raymond, Jean-Luc Raoul, Patricia Niccoli, Yung-Jue Bang, Ivan Borbath, Catherine Lombard-Bohas, Peter Metrakos, Dongrui-Ray Lu, Carolyn Blanckmeister, Aaron Vinik

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:10 -0500 C25 – Phase I study of Seneca Valley Virus (SVV-001), A Replication Competent Oncolytic Virus, in Patients with Carcinoid Cancers https://nanets.net/abstracts-archive/2009/39-phase-i-study-of-seneca-valley-virus-svv-001-a-replication-competent-oncolytic-virus-in-patients-with-carcinoid-cancers?format=html C25 – Phase I study of Seneca Valley Virus (SVV-001), A Replication Competent Oncolytic Virus, in Patients with Carcinoid Cancers CM Rudin, N Senzer, J Stephenson, K Burroughs N Senzer, T Williams

 Download Poster

]]> https://nanets.net/abstracts-archive/2009/39-phase-i-study-of-seneca-valley-virus-svv-001-a-replication-competent-oncolytic-virus-in-patients-with-carcinoid-cancers?format=html CM Rudin, N Senzer, J Stephenson, K Burroughs N Senzer, T Williams

 Download Poster

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:10 -0500 C23 – Phase II Study of Temozolomide for Relapsed Sensitive or Refractory https://nanets.net/abstracts-archive/2009/37-phase-ii-study-of-temozolomide-for-relapsed-sensitive-or-refractory?format=html C23 – Phase II Study of Temozolomide for Relapsed Sensitive or Refractory M. Catherine Pietanza, William D. Travis, Timothy A. Chan, Michelle S. Ginsberg, Andrei Holodny Mark G. Kris, Lee M. Krug

 Download Poster

]]> https://nanets.net/abstracts-archive/2009/37-phase-ii-study-of-temozolomide-for-relapsed-sensitive-or-refractory?format=html M. Catherine Pietanza, William D. Travis, Timothy A. Chan, Michelle S. Ginsberg, Andrei Holodny Mark G. Kris, Lee M. Krug

 Download Poster

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:09 -0500 C22 – Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors (PNETs): https://nanets.net/abstracts-archive/2009/36-risk-factors-for-sporadic-pancreatic-neuroendocrine-tumors-pnets?format=html C22 – Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors (PNETs): Ike Onwere, Thomas O’Dorisio, Sue M. O’Dorisio, Barry DeYoung, Menda Yusuf

 Download Poster

]]> https://nanets.net/abstracts-archive/2009/36-risk-factors-for-sporadic-pancreatic-neuroendocrine-tumors-pnets?format=html Ike Onwere, Thomas O’Dorisio, Sue M. O’Dorisio, Barry DeYoung, Menda Yusuf

 Download Poster

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:08 -0500 C20 – Gastroduodenal Ulceration Associated with Radioembolization for the Treatment of Liver Malignancies; a Newly Observed Complication https://nanets.net/abstracts-archive/2009/34-gastroduodenal-ulceration-associated-with-radioembolization-for-the-treatment-of-liver-malignancies-a-newly-observed-complication?format=html C20 – Gastroduodenal Ulceration Associated with Radioembolization for the Treatment of Liver Malignancies; a Newly Observed Complication Steven Naymagon, Richard R.P. Warner, Kalpesh Patel, Josef Machac, Joshua L. Weintraub, Michelle K. Kim

 Download Poster

]]> https://nanets.net/abstracts-archive/2009/34-gastroduodenal-ulceration-associated-with-radioembolization-for-the-treatment-of-liver-malignancies-a-newly-observed-complication?format=html Steven Naymagon, Richard R.P. Warner, Kalpesh Patel, Josef Machac, Joshua L. Weintraub, Michelle K. Kim

 Download Poster

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:07 -0500 C21 – Phase I Trial of 90Y-DOTA-tyr3-Octreotide in Children and Young Adults https://nanets.net/abstracts-archive/2009/35-phase-i-trial-of-90y-dota-tyr3-octreotide-in-children-and-young-adults?format=html C21 – Phase I Trial of 90Y-DOTA-tyr3-Octreotide in Children and Young Adults M. Sue O’Dorisio, Yusuf Menda, Stacy Michael, Simon Kao, Geetika Khanna, Mary Connelly, John Babich, Thomas O’Dorisio, David Bushnell, M.D., Mark Madsen

]]> https://nanets.net/abstracts-archive/2009/35-phase-i-trial-of-90y-dota-tyr3-octreotide-in-children-and-young-adults?format=html M. Sue O’Dorisio, Yusuf Menda, Stacy Michael, Simon Kao, Geetika Khanna, Mary Connelly, John Babich, Thomas O’Dorisio, David Bushnell, M.D., Mark Madsen

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:07 -0500 C19 – Neuroendocrine Tumors in Children and Young Adults: Incidence, Survival, and Prevalence in the United States https://nanets.net/abstracts-archive/2009/33-neuroendocrine-tumors-in-children-and-young-adults-incidence-survival-and-prevalence-in-the-united-states?format=html C19 – Neuroendocrine Tumors in Children and Young Adults: Incidence, Survival, and Prevalence in the United States P. Navalkele, M. O'Dorisio, T. M. O'Dorisio, C. F. Lynch

 Download Poster

]]> https://nanets.net/abstracts-archive/2009/33-neuroendocrine-tumors-in-children-and-young-adults-incidence-survival-and-prevalence-in-the-united-states?format=html P. Navalkele, M. O'Dorisio, T. M. O'Dorisio, C. F. Lynch

 Download Poster

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:06 -0500 C18 – Primary Gastro-entero-pancreatic Poorly Differentiated Neuroendocrine Carcinoma: Clinico-pathologic and Survival Analysis in 68 Cases https://nanets.net/abstracts-archive/2009/32-primary-gastro-entero-pancreatic-poorly-differentiated-neuroendocrine-carcinoma-clinico-pathologic-and-survival-analysis-in-68-cases?format=html C18 – Primary Gastro-entero-pancreatic Poorly Differentiated Neuroendocrine Carcinoma: Clinico-pathologic and Survival Analysis in 68 Cases Aejaz Nasir, Mulazim H. Bukhari, Elizabeth Byron, Jonathan R. Strosberg, Evita B. Henderson-Jackson, Domenico Coppola, Larry K. Kvols

]]> https://nanets.net/abstracts-archive/2009/32-primary-gastro-entero-pancreatic-poorly-differentiated-neuroendocrine-carcinoma-clinico-pathologic-and-survival-analysis-in-68-cases?format=html Aejaz Nasir, Mulazim H. Bukhari, Elizabeth Byron, Jonathan R. Strosberg, Evita B. Henderson-Jackson, Domenico Coppola, Larry K. Kvols

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:05 -0500 C17 – RUNX1T1: A Novel Predictor of Liver Metastasis in Primary Pancreatic https://nanets.net/abstracts-archive/2009/31-runx1t1-a-novel-predictor-of-liver-metastasis-in-primary-pancreatic?format=html C17 – RUNX1T1: A Novel Predictor of Liver Metastasis in Primary Pancreatic Aejaz Nasir, James Helm, Leslie M. Turner, Evita B Henderson-Jackson, Jonathan R. Strosberg, Nelly A. Nasir, Ardeshir Hakam, Domenico Coppola, Larry K. Kvols

]]> https://nanets.net/abstracts-archive/2009/31-runx1t1-a-novel-predictor-of-liver-metastasis-in-primary-pancreatic?format=html Aejaz Nasir, James Helm, Leslie M. Turner, Evita B Henderson-Jackson, Jonathan R. Strosberg, Nelly A. Nasir, Ardeshir Hakam, Domenico Coppola, Larry K. Kvols

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:04 -0500 C16 – Identification of Unknown Primary Tumors in Patients with Neuroendocrine Liver Metastases https://nanets.net/abstracts-archive/2009/30-identification-of-unknown-primary-tumors-in-patients-with-neuroendocrine-liver-metastases?format=html C16 – Identification of Unknown Primary Tumors in Patients with Neuroendocrine Liver Metastases Sam C. Wang, Justin R. Parekh, Marlene B. Zuraek, Alan P. Venook, Emily K. Bergsland, Robert S. Warren, Eric K. Nakakura

]]> https://nanets.net/abstracts-archive/2009/30-identification-of-unknown-primary-tumors-in-patients-with-neuroendocrine-liver-metastases?format=html Sam C. Wang, Justin R. Parekh, Marlene B. Zuraek, Alan P. Venook, Emily K. Bergsland, Robert S. Warren, Eric K. Nakakura

]]> support@adgcommunications.com (Super User) 2009 Thu, 15 Feb 2018 10:07:03 -0500